GlassScriptPhysician profile
Kevin Wotring
NPI 1548901168
$5,322.22
in general payments reported to CMS, 2019-2025
13 companies · $2,678 in 2025
The $2,678 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $255 · 2023: $776 · 2024: $1,613 · 2025: $2,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,329 · Travel and Lodging: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,328.97 |
| Travel and Lodging | $738.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,416.24 | 2023-2025 | Augment Injectable, Ortholoc 3di, Prostep Mica |
| Smith+Nephew, INC. | $490.37 | 2023-2025 | Grafix Pl, Stravix Pl, Oasis |
| Horizon Therapeutics Plc | $364.62 | 2022-2023 | Krystexxa |
| Novus Surgical Consultants | $335.60 | 2023-2025 | |
| Cerapedics INC. | $130.50 | 2022 | |
| Alexion Pharmaceuticals, INC. | $124.74 | 2024 | Strensiq |
| Amgen INC. | $124.74 | 2024 | Krystexxa |
| Kci USA, INC. | $86.50 | 2023 | V.A.C. Veraflo Cleanse Choice, Activ.A.C. Ion Progress |
| Treace Medical Concepts, INC. | $70.77 | 2025 | |
| Trice Medical, INC. | $61.62 | 2025 | |
| Depuy Synthes Sales INC. | $57.15 | 2025 | Na |
| Kuros Biosciences USA, INC | $36.01 | 2025 | Magnetos |
| Acumed LLC | $23.36 | 2025 | Acumed, Innate Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Wotring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.